
At the ADA Scientific Sessions in New Orleans, Abbott shared results of the IMPACT study, a randomized six-month trial comparing the FreeStyle Libre “flash glucose monitor” to fingersticks in people with type 1 diabetes
At the ADA Scientific Sessions in New Orleans, Abbott shared results of the IMPACT study, a randomized six-month trial comparing the FreeStyle Libre “flash glucose monitor” to fingersticks in people with type 1 diabetes